Lactic Acid Bacteria-Gut-Microbiota-Mediated Intervention towards Inflammatory Bowel Disease

被引:2
作者
Li, Diantong [1 ,2 ]
Liu, Zhenjiang [1 ,3 ]
Fan, Xueni [1 ,2 ]
Zhao, Tingting [1 ,2 ]
Wen, Dongxu [1 ]
Huang, Xiaodan [1 ,2 ]
Li, Bin [1 ]
机构
[1] Xizang Acad Agr & Anim Husb Sci, Inst Anim Husb & Vet, Key Lab Anim Genet & Breeding Tibetan Plateau, Minist Agr & Rural Affairs, Lhasa 850000, Peoples R China
[2] Lanzhou Univ, Sch Publ Hlth, Lanzhou 730000, Peoples R China
[3] Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China
关键词
inflammatory bowel disease; ulcerative colitis; Crohn's disease; lactic acid bacteria; INTESTINAL EPITHELIAL-CELLS; AMBIENT AIR-POLLUTION; CHAIN FATTY-ACIDS; ULCERATIVE-COLITIS; PROBIOTIC VSLNUMBER-3; EMERGING ROLE; NOD2; AMOXICILLIN; THERAPY; MECHANISMS;
D O I
10.3390/microorganisms12091864
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), arises from intricate interactions involving genetics, environment, and pharmaceuticals with an ambiguous pathogenic mechanism. Recently, there has been an increasing utilization of lactic acid bacteria (LAB) in managing IBD, attributed to their ability to enhance intestinal barrier function, mitigate inflammatory responses, and modulate gut microbiota. This review initiates by elucidating the pathogenesis of IBD and its determinants, followed by an exploration of the mechanisms underlying LAB therapy in UC and CD. Special attention is directed towards their influence on intestinal barrier function and homeostasis regulated by gut microbiota. Furthermore, the review investigates the complex interplay among pivotal gut microbiota, metabolites, and pathways associated with inflammation. Moreover, it underscores the limitations of LAB in treating IBD, particularly in light of their varying roles in UC and CD. This comprehensive analysis endeavors to offer insights for the optimized application of LAB in IBD therapy.
引用
收藏
页数:15
相关论文
共 50 条
[31]   Role of gut microbiota in inflammatory bowel disease pathogenesis [J].
Naito, Yuji ;
Takagi, Tomohisa .
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2024, 75 (03) :175-177
[32]   Diet and microbiota in inflammatory bowel disease: The gut in disharmony [J].
Rapozo, Davy C. M. ;
Bernardazzi, Claudio ;
Pereira de Souza, Heitor Siffert .
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (12) :2124-2140
[33]   Diet and microbiota in inflammatory bowel disease: The gut in disharmony [J].
Davy CM Rapozo ;
Claudio Bernardazzi ;
Heitor Siffert Pereira de Souza .
World Journal of Gastroenterology, 2017, (12) :2124-2140
[34]   Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease [J].
Ekstedt, Natalia ;
Jamiol-Milc, Dominika ;
Pieczynska, Joanna .
NUTRIENTS, 2024, 16 (13)
[35]   Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission [J].
Pisani, Anthea ;
Rausch, Philipp ;
Bang, Corinna ;
Ellul, Sarah ;
Tabone, Trevor ;
Cordina, Claire Marantidis ;
Zahra, Graziella ;
Franke, Andre ;
Ellul, Pierre .
MICROBIOLOGY SPECTRUM, 2022, 10 (03)
[36]   Exploring the Connections: Autophagy, Gut Microbiota, and Inflammatory Bowel Disease Pathogenesis [J].
Subramanian, Arunkumar ;
Afrarahamed, J. ;
Tamilanban, T. ;
Kumarasamy, Vinoth ;
Begum, M. Yasmin ;
Sekar, Mahendran ;
Subramaniyan, Vetriselvan ;
Wong, Ling Shing ;
Al Fatease, Adel .
JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 :10453-10470
[37]   Neuroimmune interactions: The bridge between inflammatory bowel disease and the gut microbiota [J].
Zhai, Jinxia ;
Li, Yingjie ;
Liu, Jiameng ;
Dai, Cong .
CLINICAL AND TRANSLATIONAL MEDICINE, 2025, 15 (05)
[38]   Improvement of inflammatory bowel disease by lactic acid bacteria-derived metabolites: a review [J].
Guo, Weiling ;
Mao, Bingyong ;
Tang, Xin ;
Zhang, Qiuxiang ;
Zhao, Jianxin ;
Zhang, Hao ;
Chen, Wei ;
Cui, Shumao .
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2025, 65 (07) :1261-1278
[39]   Role of Gut Microbiota and Metabolomics in Predicting Response to Vedolizumab in Inflammatory Bowel Disease: A Systematic Review [J].
Malinauskiene, Vaidota ;
Cijauskaite, Elena ;
Sadauskaite, Goda ;
Stundiene, Ieva .
PHARMACEUTICS, 2025, 17 (04)
[40]   The role of the fecal microbiota in inflammatory bowel disease [J].
Khalaf, Rami ;
Sciberras, Martina ;
Ellul, Pierre .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (11) :1249-1258